Skip to main content
Sandra Juul, MD, Neonat/Perinatology, Seattle, WA, UW Medicine/University of Washington Medical Center

SandraEJuulMDPhD

Neonat/Perinatology • Seattle, WA

Neonatal Neurodevelopment

Professor of Pediatrics

Join to view full profile

Dr. Juul is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Juul's full profile

Already have an account?

Summary

  • Dr. Sandra ”Sunny” Juul, MD, PhD is Division Chief of Neonatology at Seattle Children’s Hospital and the University of Washington. After completing her medical degree, residency, fellowship and two years as an acting Assistant Professor at the University of Washington, Dr. Juul left Seattle in 1991 for the University of Chicago where she began a Ph.D. in Developmental Biology. She then joined the faculty at the University of Florida in 1993, where her Ph.D. work was completed. In 2000, Dr. Juul was successfully recruited back to Seattle. She is board certified in Pediatrics and Neonatology.

    Dr. Juul leads a translational neonatal neuroscience research program. The focus is to identify new therapeutic approaches to neonatal brain injury, determine whether they are safe and effective, and if so, bring these new treatments from the laboratory to the bedside. Dr. Juul identified Epo and its receptor in the developing human brain, demonstrated that it is neuroprotective and safe using multiple animal models of neonatal brain injury. Bringing this work from the bench to the bedside, Dr. Juul is currently Principal Investigator of a multicenter randomized controlled trial to determine whether Epo is a safe and effective neuroprotectant for extremely preterm infants. The study, Preterm Epo Neuroprotection (PENUT) is funded by NINDS, and has enrolled 940 babies born between 24-0/7 and 26-6/7 weeks of gestation. These children are currently being followed to two years of age for detailed neurodevelopmental assessments. Dr. Juul is also multi-PI with Dr. Yvonne Wu (UCSF) on the High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) Trial, a randomized controlled trial of Epo neuroprotection for 500 term infants with hypoxic-ischemic encephalopathy (HIE). This multicenter trial will determine whether Epo in addition to therapeutic cooling will improve the outcome for infants with HIE.

Education & Training

  • University of Chicago
    University of ChicagoPhD, Developmental Biology, 1991 - 1997
  • University of Washington
    University of WashingtonFellowship, Neonatal-Perinatal Medicine, 1986 - 1989
  • University of Washington
    University of WashingtonChief Residency, Pediatrics, 1985 - 1986
  • University of Washington
    University of WashingtonResidency, Pediatrics, 1981 - 1984
  • University of Washington School of Medicine
    University of Washington School of MedicineClass of 1981

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1982 - 2026
  • FL State Medical License
    FL State Medical License 1993 - 2002
  • IL State Medical License
    IL State Medical License 1991 - 1993
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Neonatal-Perinatal Medicine

Awards, Honors, & Recognition

  • Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates  
    Sandra E Juul, Dennis E Mayock, Kaashif A Ahmad, Ellen Bendel-Stenzel, Mariana Baserga, Edmund F Lagamma, Nancy Fahim, Andrea Lampland, Ivan D Frantz, Janine Khan, Mau..., JAMA Pediatrics
  • A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants  
    Sandra Juul, MD, The New England Journal of Medicine

Authored Content

  • Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age NeonatesAugust 2020
  • Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age NeonatesAugust 2020

Grant Support

  • Optimizing Neuroprotection Following Perinatal AsphyxiaNational Center For Research Resources2010–2011
  • Optimizing Neuroprotection Following Perinatal AsphyxiaEunice Kennedy Shriver National Institute Of Child Health &Human Development2007–2011
  • EPO Neuroprotection Of ELBW Infants: Planning GrantNational Institute Of Neurological Disorders And Stroke2010
  • Optimizing Neuroprotection Following Neonatal Hypoxic-Ischemic Brain InjuryNational Center For Research Resources2009
  • Safety &Efficacy Of R-Erythropoietin As A Rescue AgentNational Center For Research Resources2006
  • Safety And Efficacy Of Recombinant Erythropoietin (REPO) As A Rescue Agent For ANational Center For Research Resources2004–2005
  • Pharmacokinetics Of Erythropoietin In The CSF Of Macaques NemestrinaNational Center For Research Resources2004–2005
  • Optimizing Iron Status In The Preterm NeonateNational Center For Research Resources2004–2005
  • EPO As A Rescue Agent For Perinatal Hypoxia-IschemiaEunice Kennedy Shriver National Institute Of Child Health &Human Development2002–2004
  • Nonhematopoietic Developmental Functions Of EPOEunice Kennedy Shriver National Institute Of Child Health &Human Development2001–2004
  • Idiopathic Neutropenia In NeonatesNational Center For Research Resources1999–2001
  • Nonhematopoietic Development Function Of ErythropoietinNational Center For Research Resources2000
  • Erythropoietin Concentration In Human MilkNational Center For Research Resources2000
  • Effect Of Meningitis Intraventricular Hemorrhage And Birth AsphyxiaNational Center For Research Resources1998–2000

Professional Memberships

Hospital Affiliations

External Links

Dr. Sandra Juul, Dr. Sandra Juul, MD, Dr. S Juul, Dr. Sandra E Juul